Paganelli G - Search Results

1

Dosimetric Approaches for Radioimmunotherapy of Non-Hodgkin Lymphoma in Myeloablative Setting.

Cicone F, Sarnelli A, Guidi C, Belli ML, Ferrari ME, Wahl R, Cremonesi M, Paganelli G. Cicone F, et al. Among authors: paganelli g. Semin Nucl Med. 2022 Mar;52(2):191-214. doi: 10.1053/j.semnuclmed.2021.11.001. Epub 2022 Jan 5. Semin Nucl Med. 2022. PMID: 34996594 Review.

2

High-dose radioimmunotherapy with 90Y-ibritumomab tiuxetan: comparative dosimetric study for tailored treatment.

Cremonesi M, Ferrari M, Grana CM, Vanazzi A, Stabin M, Bartolomei M, Papi S, Prisco G, Ferrucci PF, Martinelli G, Paganelli G. Cremonesi M, et al. Among authors: paganelli g. J Nucl Med. 2007 Nov;48(11):1871-9. doi: 10.2967/jnumed.107.044016. J Nucl Med. 2007. PMID: 17978355 Free article. Clinical Trial.

3

Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical study.

Botta F, Cremonesi M, Ferrari ME, Amato E, Guerriero F, Vavassori A, Sarnelli A, Severi S, Pedroli G, Paganelli G. Botta F, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2013 Jul;40(7):1047-56. doi: 10.1007/s00259-013-2383-1. Epub 2013 May 3. Eur J Nucl Med Mol Imaging. 2013. PMID: 23640466

4

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group.

Chinol M, Bodei L, Cremonesi M, Paganelli G. Chinol M, et al. Among authors: paganelli g. Semin Nucl Med. 2002 Apr;32(2):141-7. doi: 10.1053/snuc.2002.31563. Semin Nucl Med. 2002. PMID: 11965609 Clinical Trial.

5

Dosimetric model for locoregional treatments of brain tumors with 90Y-conjugates: clinical application with 90Y-DOTATOC.

Ferrari M, Cremonesi M, Bartolomei M, Bodei L, Chinol M, Fiorenza M, Tosi G, Paganelli G. Ferrari M, et al. Among authors: paganelli g. J Nucl Med. 2006 Jan;47(1):105-12. J Nucl Med. 2006. PMID: 16391194 Free article. Clinical Trial.

6

Radioimmunotherapy of brain tumor.

Paganelli G, Bartolomei M, Grana C, Ferrari M, Rocca P, Chinol M. Paganelli G, et al. Neurol Res. 2006 Jul;28(5):518-22. doi: 10.1179/016164106X116782. Neurol Res. 2006. PMID: 16808882 Review.

7

Radiation protection in radionuclide therapies with (90)Y-conjugates: risks and safety.

Cremonesi M, Ferrari M, Paganelli G, Rossi A, Chinol M, Bartolomei M, Prisco G, Tosi G. Cremonesi M, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2006 Nov;33(11):1321-7. doi: 10.1007/s00259-006-0151-1. Epub 2006 Jul 11. Eur J Nucl Med Mol Imaging. 2006. PMID: 16832636

8

Dosimetry in Peptide radionuclide receptor therapy: a review.

Cremonesi M, Ferrari M, Bodei L, Tosi G, Paganelli G. Cremonesi M, et al. Among authors: paganelli g. J Nucl Med. 2006 Sep;47(9):1467-75. J Nucl Med. 2006. PMID: 16954555 Free article. Review.

9

High activity 90Y-ibritumomab tiuxetan (Zevalin) with peripheral blood progenitor cells support in patients with refractory/resistant B-cell non-Hodgkin lymphomas.

Ferrucci PF, Vanazzi A, Grana CM, Cremonesi M, Bartolomei M, Chinol M, Ferrari M, Radice D, Papi S, Martinelli G, Paganelli G. Ferrucci PF, et al. Among authors: paganelli g. Br J Haematol. 2007 Nov;139(4):590-9. doi: 10.1111/j.1365-2141.2007.06869.x. Br J Haematol. 2007. PMID: 17979944 Free article.

10

Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatment.

Cremonesi M, Ferrari M, Bartolomei M, Orsi F, Bonomo G, Aricò D, Mallia A, De Cicco C, Pedroli G, Paganelli G. Cremonesi M, et al. Among authors: paganelli g. Eur J Nucl Med Mol Imaging. 2008 Nov;35(11):2088-96. doi: 10.1007/s00259-008-0857-3. Epub 2008 Jul 10. Eur J Nucl Med Mol Imaging. 2008. PMID: 18618108

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

416 results

Search Page